CD8A and COVID-19: Studies have noted that circulating SARS-CoV-2-specific CD8+ and CD4+ T cells existed in 70% and 100% of convalescent COVID-19 patients respectively 45, indicating that almost all SARS-CoV-2 infections elicit the T cell response, especially CD4+ T cell responses.